Study Evaluating Bifeprunox in Patients With Schizophrenia.

NCT00366327 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Bifeprunox

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer